Search results
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio Now
Zacks via Yahoo Finance· 2 hours agoNew Product Launch: In March, DexCom received FDA approval for its new glucose sensor, Stelo,...
The Zacks Analyst Blog Highlights Blue Bird Corp, General Motors and Dorman Products
Zacks via Yahoo Finance· 1 hour agoIn the trailing four quarters, the stock surpassed estimates on all occasions, the average surprise...
Zacks Initiates Coverage of Omega Flex With Neutral Recommendation
Zacks via Yahoo Finance· 1 hour agoDiscover why Zacks gives Omega Flex a 'Neutral' rating, being the first on Wall Street to initiate...
Steve Kornacki's Guide to the Preakness: Will Mystik Dan take the second leg of the Triple Crown?
NBC News via Yahoo Sports· 2 hours agoBrown’s success with that kind of move makes Tuscan Gold an intriguing possibility here. With just...
Is ORNAX a Strong Bond Fund Right Now?
Zacks via Yahoo Finance· 2 hours agoExpenses Costs are increasingly important for mutual fund investing, and particularly as competition heats up in this market. And all things being equal,...
Zacks Industry Outlook Highlights Estee Lauder, Coty, Helen of Troy and European Wax Center
Zacks via Yahoo Finance· 2 hours agoCoty’s shares have dipped 1.9% in the past six months. Helen of Troy: This provider of consumer ...
Royal news – live: Queen Camilla issues playful warning to King Charles about his ongoing cancer...
The Independent via Yahoo News· 2 hours agoRead the full article here: Queen Camilla promises to buy no more clothes with real fur 05:00 ,...
Should You Buy Nvidia Stock Before May 22?
Motley Fool via Yahoo Finance· 2 hours agoThat's on total revenue of about $22 billion (also a record) and significantly more than gaming revenue of $2.9 billion. In addition to GPUs, Nvidia...
Piper Sandler sees Fed cutting rates three times over the next 8 meetings By Investing.com
Investing.com· 3 hours agoThe investment firm notes that the probability of extreme outcomes, such as significant hikes or...
Earnings call: Eyenovia reports Q1 2024 results, focuses on product pipeline By Investing.com
Investing.com· 21 hours agoEyenovia, Inc. (NASDAQ:EYEN), a biopharmaceutical company specializing in ophthalmic diseases,...
